Over the past six months, Zimmer Biomet’s shares (currently trading at $86.64) have posted a disappointing 6.2% loss, well below the S&P 500’s 9.6% gain. This might have investors contemplating their ...

Musculoskeletal product breadth supports procedural demand Global healthcare footprint remains diversified Broader market ...

The upcoming report from Zimmer Biomet (ZBH) is expected to reveal quarterly earnings of $2.38 per share, indicating an increase of 3% compared to the year-ago period. Analysts forecast revenues of $2 ...

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is included on our list of the best undervalued wide moat stocks. On January 13, 2026, Zimmer Biomet Holdings, Inc. (NYSE:ZBH) laid out cautious expectations ...

Zimmer Biomet (NYSE: ZBH) announced today that it received FDA 510(k) clearance for its G7 acetabular system for hip ...

Is On Investors’ Radar Today Zimmer Biomet Holdings (ZBH) is back in focus after recent share price moves, with the stock showing a negative 1 day return and mixed performance over the past week, ...

Investors in Zimmer Biomet Holdings Inc (Symbol: ZBH) saw new options begin trading today, for the March 2026 expiration. One of the key data points that goes into the price an option buyer is willing ...

Zimmer Biomet ZBH and RevelAi Health accepted a multi-year co-marketing agreement to commercialize generative artificial intelligence (AI)-powered engagement solutions, which, in turn, should help the ...

Zimmer Biomet (ZBH) could be a strong choice for your investment portfolio, due to its high cash yield, solid fundamentals, and discounted valuation. Companies like this have the capacity to leverage ...

Scout Investments, Inc., an affiliate of Carillon Tower Advisers, released the “Carillon Scout Mid Cap Fund” second quarter 2025 investor letter. A copy of the letter can be downloaded here. The ...